About Moffitt Cancer Center - Magnolia Campus
"At Moffitt Cancer Center, we are working tirelessly in the areas of patient care, research and education to advance one step further in fighting cancer."
Clinical Trials at Moffitt Cancer Center - Magnolia Campus
During the past decade, Moffitt Cancer Center - Magnolia Campus conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Moffitt Cancer Center - Magnolia Campus"
#1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "Norfolk and Norwich University Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Zuyderland Medical Centre" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Moffitt Cancer Center - Magnolia Campus
According to Clinical.Site data, the most researched conditions in "Moffitt Cancer Center - Magnolia Campus" are
"Cutaneous Melanoma, Stage II" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Moffitt Cancer Center - Magnolia Campus" in a lesser frequency.
Clinical Trials Intervention Types at Moffitt Cancer Center - Magnolia Campus
Most popular intervention types in "Moffitt Cancer Center - Magnolia Campus" are "Biological" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Wide Local Excision = 1cm Margin" (1 trials), "Wide Local Excision = 2cm Margin" (1 trials), "docetaxel" (1 trials), "pembrolizumab" (1 trials) and "quaratusugene ozeplasmid" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Moffitt Cancer Center - Magnolia Campus
The vast majority of trials in "Moffitt Cancer Center - Magnolia Campus" are
2 trials for "All" genders.
Clinical Trials Status at Moffitt Cancer Center - Magnolia Campus
Currently, there are NaN active trials in "Moffitt Cancer Center - Magnolia Campus".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Moffitt Cancer Center - Magnolia Campus,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Moffitt Cancer Center - Magnolia Campus, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".